Global Patients is currently looking for adults diagnosed with cancer that may be taking a biosimilar version of Avastin, Herceptin or Rituxan to participate in an upcoming paid interview study in the US.
The purpose of this study is to explore patients´general perceptions and knowledge of oncology biosimilars. It will involve a 45-minute telephone interview. Your information will be confidential.
We appreciate the time that patients invest, for this reason if you qualify for the study and participate in the telephone interview providing a confirmation of diagnosis you will receive 150USD for your time.
If you have been diagnosed with cancer and are interested in participating or would like more information about the study, please contact email@example.com